- Cost savings recognised and achieved post-merger
- EBITDA positive by EOFY21 per previous guidance
- Integration of product suite achieved on time and on budget
- Cross-selling of new products "already well underway"
Exactly what we needed to hear.
EBITDA is the call-out as being CF+ after such a large acquisition is the number one concern. The co is confident it will deliver on Feb 2020 guidance.
Great update. Would be nice to hear more about the agreements signed over the past 6 months.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
8.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $126.3M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 8.7¢ | 8.7¢ | $126.0K | 1.449M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2708208 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.8¢ | 573057 | 7 |
View Market Depth
| Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
| EVS (ASX) Chart |